Uristat Ultra Tablet
FDA Label NDC 63029-105

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medtech Products Inc. for the product Uristat Ultra (NDC 63029-105). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, use, warnings, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient (In Each Tablet)

Phenazopyridine hydrochloride 99.5 mg

Purpose

Urinary analgesic

Use

fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections

Warnings

Do not exceed recommended dosage

Ask A Doctor Before Use If You Have

  • kidney disease 
  • allergies to foods, preservatives, or dyes
  • had a hypersensitive reaction to phenazopyridine

When Using This Product

  • stomach upset may occur. Taking this product with or after meals may reduce stomach upset
  • your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.

Stop Use And Ask A Doctor If

  • your symptoms last for more than 2 days
  • you suspect you are having an adverse reaction to the medication

If Pregnant Or Breast-Feeding,

ask a health care professional before use. 

Keep Out Of Reach Of Children.

In case of an overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. 

Directions

  • Adults and children 12 years of age and over: take 2 tablets 3 times daily with a full glass of water, with or after meals as needed
  • Children under 12 years of age: consult a doctor.
  • Do not use for more than 2 days (12 tablets) without consulting a doctor

Other Information

  • This product may stain contact lenses
  • This product can interfere with laboratory tests including urine, glucose (sugar), and ketones test
  • Long term administration of phenazopyridine HCl has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted
  • Store at 20°-25° C (68°-77° F) in a dry place and protect from light.

Inactive Ingredients

croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil, polyethylene glycol, povidone, pregelatinized starch, silica and starch.

Questions?

1-800-344-7239  Uristat.com

©2017 Distributed by Insight Pharmaceuticals LLC
Tarrytown, NY 10591, a Prestige Brands Company

Principal Display Panel

URISTAT® ULTRA

UTI Pain Relief Tablets

Phenazopyridine Hydrochloride  99.5 mg

30 Urinary Pain Relief Tablets

Uristat® Ultrauti Pain Relief Tabletsphenazopyridine Hydrochloride  99.5 mg30 Urinary Pain Relief Tablets (Uristat Ultra 01)

Uristat® Ultrauti Pain Relief Tabletsphenazopyridine Hydrochloride 99.5 mg30 Urinary Pain Relief Tablets (Uristat Ultra 01)

URISTAT® ULTRA

UTI Relief PAK™

Phenazopyridine Hydrochloride  99.5 mg

1 UTI Test Strip and 12 Urinary Pain Relief Tablets

Uti Relief Pak™phenazopyridine Hydrochloride  99.5 mg1 Uti Test Strip And 12 Urinary Pain Relief Tablets (Uristat Ultra 02)

Uti Relief Pak™phenazopyridine Hydrochloride 99.5 mg1 Uti Test Strip And 12 Urinary Pain Relief Tablets (Uristat Ultra 02)

* Please review the disclaimer below.